Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glioma Subclassifications and Their Clinical Significance.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics - 1 Apr 2017

Chen Ricky, Smith-Cohn Matthew, Cohen Adam L, Colman Howard

Abstract excerpt

The impact of targeted therapies in glioma has been modest. All the therapies that have demonstrated a significant survival benefit for gliomas in Phase III trials, including radiation, chemotherapy (temozolomide and PCV [procarbazine, lomustine, vincristine]), and tumor-treating fields, are based on nonspecific targeting of proliferating cells. Recent advances in the molecular understanding of gliomas suggest...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Gene Deletion
Share to Gene Expression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glioma

Share to Molecular Targeted Therapy

Share to Mutation

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 28281173
DOI: 10.1007/s13311-017-0519-x
PMCID: PMC5398991

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glioma Subclassifications and Their Clinical Significance.PMID 28281173Read ↗

Adult Glioma WHO Classification Update, Genomics, and ImagingSemantic proximity Read ↗

Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?Semantic proximity Read ↗

Applicable advances in the molecular pathology of glioblastoma.Semantic proximity Read ↗

Practical molecular pathologic diagnosis of infiltrating gliomas.Semantic proximity Read ↗

Molecular pathology and clinical implications of diffuse glioma.Semantic proximity Read ↗

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Biomarkers classification and therapeutic decision-making for malignant gliomas.Semantic proximity Read ↗

CNS cancer: molecular classification of glioma.Semantic proximity Read ↗

Advances in the molecular genetics of gliomas — implications for classification and therapySemantic proximity Read ↗

Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.Semantic proximity Read ↗

Treatment of Adult Lower-Grade Glioma in the Era of Genomic Medicine.Semantic proximity Read ↗

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.